Novo Holdings A/S’s Verona Pharma VRNA Stock Holding History

Novo Holdings A/S’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-761,205	Closed	-$3.19M	–	54
2022 Q2	$3.19M	Hold	761,205	–	–	0.16%	52
2022 Q1	$3.8M	Hold	761,205	–	–	0.2%	49
2021 Q4	$5.12M	Hold	761,205	–	–	0.24%	44
2021 Q3	$4.17M	Hold	761,205	–	–	0.22%	45
2021 Q2	$4.98M	Sell	761,205 -77,155	-9%	-$535K	0.22%	50
2021 Q1	$7.01M	Sell	838,360 -1,770,395	-68%	-$14.7M	0.29%	43
2020 Q4	$18.3M	Buy	2,608,755 +808,008	+45%	+$5.46M	0.78%	23
2020 Q3	$11.2M	Buy	1,800,747 +1,060,007	+143%	+$7.32M	0.56%	26
2020 Q2	$3.47M	Hold	740,740	–	–	0.22%	34
2020 Q1	$3.05M	Hold	740,740	–	–	0.2%	27
2019 Q4	$4.26M	Hold	740,740	–	–	0.27%	23
2019 Q3	$3.38M	Hold	740,740	–	–	0.58%	24
2019 Q2	$3.78M	Hold	740,740	–	–	0.53%	24
2019 Q1	$4.82M	Hold	740,740	–	–	0.71%	19
2018 Q4	$7.15M	Hold	740,740	–	–	1.01%	16
2018 Q3	$9.27M	Hold	740,740	–	–	0.74%	17
2018 Q2	$10.1M	Hold	740,740	–	–	1.02%	13
2018 Q1	$14.8M	Hold	740,740	–	–	1.86%	10
2017 Q4	$8.79M	Hold	740,740	–	–	1.23%	9
2017 Q3	$11.4M	Hold	740,740	–	–	1.48%	14
2017 Q2	$8.64M	Buy	+740,740	New	+$9.81M	1.03%	17

Other funds holding VRNA

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Novo Holdings A/S's VRNA Position: Q3 2022 in Review

Novo Holdings A/S sold out of Verona Pharma (VRNA) in Q3 2022, closing a stake of 761,205 shares — an estimated $3.19M sold.

Novo Holdings A/S first reported a position in VRNA in Q2 2017 and held it in 21 quarters. The position peaked at $18.3M in Q4 2020. 68 funds tracked by Wall St. Rank hold VRNA as of Q3 2022.

Novo Holdings A/S reported no remaining Verona Pharma position as of Q3 2022 after selling out during the quarter.
Novo Holdings A/S sold 761,205 Verona Pharma shares in Q3 2022, an estimated $3.19M.
Novo Holdings A/S first reported a position in Verona Pharma in Q2 2017 and held it in 21 quarters.
Novo Holdings A/S's Verona Pharma position peaked at $18.3M in Q4 2020.
68 funds tracked by Wall St. Rank held Verona Pharma as of Q3 2022.

Based on Novo Holdings A/S's 13F filing for Q3 2022, filed 14 Nov 2022.